易居企業(02048.HK)正進行境外重組 向美國破產法院提交自願濟助呈請
易居企業控股(02048.HK)公布,有關公司正進行一項名為「關於易居(中國)企業控股有限公司」的境外重組程序,涉及公司與計劃債權人根據開曼群島公司法的安排計劃,目前尚待開曼群島大法院審理。而公司境外代表Alexander Lawson於昨日(4日),根據美國《破產法》,為公司向美國紐約南區破產法院提交自願濟助呈請及認可境外主要程序、認可境外代表及若干相關濟助之核證呈請。
有關核證呈請要求根據《破產法》下達命令,承認開曼程序為境外主要程序,授予相關濟助,執行計劃、開曼程序及開曼命令,以及授予若干額外濟助。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.